Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Dietlein

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|April 7, 2022
Genome-wide analysis of somatic noncoding mutation patterns in cancerFelix Dietlein, Alex B Wang, Christian Fagre, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2019
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate CancerFelix Dietlein, Carsten Kobe, Melanie Hohberg, et al.
Molecular Imaging and Biology|May 28, 2015
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate CancerMarkus Dietlein, Carsten Kobe, Georg Kuhnert, et al.
EJNMMI Research|July 27, 2019
Biodistribution and radiation dosimetry of [<sup>18</sup>F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancerMelanie Hohberg, Carsten Kobe, Philipp Krapf, et al.
Oncogene|July 5, 2018
Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancerKristina Golfmann, Lydia Meder, Mirjam Koker, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancerKaiyang Zhang, Essi Kahelin, Giovanni Marchi, et al.
Oncogene|March 6, 2018
LIN28B enhanced tumorigenesis in an autochthonous KRAS<sup>G12V</sup>-driven lung carcinoma mouse modelLydia Meder, Katharina König, Felix Dietlein, et al.
Oncotarget|November 6, 2015
Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancerJakob Schöttle, Sampurna Chatterjee, Caroline Volz, et al.
Nature Genetics|November 24, 2020
Integrated molecular drivers coordinate biological and clinical states in melanomaJake R Conway, Felix Dietlein, Amaro Taylor-Weiner, et al.
Nature Communications|April 3, 2026
Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancerJasmine George, Xiaolong Ma, Ishaque Pulikkal Kadamberi, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|April 7, 2022
Genome-wide analysis of somatic noncoding mutation patterns in cancerFelix Dietlein, Alex B Wang, Christian Fagre, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2019
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate CancerFelix Dietlein, Carsten Kobe, Melanie Hohberg, et al.
Molecular Imaging and Biology|May 28, 2015
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate CancerMarkus Dietlein, Carsten Kobe, Georg Kuhnert, et al.
EJNMMI Research|July 27, 2019
Biodistribution and radiation dosimetry of [<sup>18</sup>F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancerMelanie Hohberg, Carsten Kobe, Philipp Krapf, et al.
Oncogene|July 5, 2018
Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancerKristina Golfmann, Lydia Meder, Mirjam Koker, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancerKaiyang Zhang, Essi Kahelin, Giovanni Marchi, et al.
Oncogene|March 6, 2018
LIN28B enhanced tumorigenesis in an autochthonous KRAS<sup>G12V</sup>-driven lung carcinoma mouse modelLydia Meder, Katharina König, Felix Dietlein, et al.
Oncotarget|November 6, 2015
Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancerJakob Schöttle, Sampurna Chatterjee, Caroline Volz, et al.
Nature Genetics|November 24, 2020
Integrated molecular drivers coordinate biological and clinical states in melanomaJake R Conway, Felix Dietlein, Amaro Taylor-Weiner, et al.
Nature Communications|April 3, 2026
Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancerJasmine George, Xiaolong Ma, Ishaque Pulikkal Kadamberi, et al.
Pageof 5